Gene · 2646
Papers2,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies. | Chin Med | 2024 | 38310315 | PubTator, text mining | PubMed |
| Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver Disease. | Gastro Hep Adv | 2024 | 38292457 | PubTator, text mining | PubMed |
| Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. | Sci Adv | 2024 | 38277453 | PubTator, text mining | PubMed |
| Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. | Viruses | 2024 | 38257811 | PubTator, text mining | PubMed |
| Unique Genetic Features of Lean NAFLD: A Review of Mechanisms and Clinical Implications. | J Clin Transl Hepatol | 2024 | 38250459 | PubTator, text mining | PubMed |
| Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice. | J Pers Med | 2024 | 38248762 | PubTator, text mining | PubMed |
| Coffee consumption affects kidney function based on GCKR polymorphism in a Korean population. | Nutr Res | 2024 | 38215572 | PubTator, text mining | PubMed |
| New-Generation Glucokinase Activators: Potential Game-Changers in Type 2 Diabetes Treatment. | Int J Mol Sci | 2024 | 38203742 | PubTator, text mining | PubMed |
| What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside. | J Clin Med | 2024 | 38202285 | PubTator, text mining | PubMed |
| Defining type 2 diabetes polygenic risk scores through colocalization and network-based clustering of metabolic trait genetic associations. | Genome Med | 2024 | 38200577 | PubTator, text mining | PubMed |
| Mendelian randomization identifies circulating proteins as biomarkers for age at menarche and age at natural menopause. | Commun Biol | 2024 | 38184718 | PubTator, text mining | PubMed |
| Astrocytes Drive Divergent Metabolic Gene Expression in Humans and Chimpanzees. | Genome Biol Evol | 2024 | 38159045 | PubTator, text mining | PubMed |
| The Relationship of Circulating Choline and Choline-Related Metabolite Levels with Health Outcomes: A Scoping Review of Genome-Wide Association Studies and Mendelian Randomization Studies. | Adv Nutr | 2024 | 38128611 | PubTator, text mining | PubMed |
| ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits. | Cell Metab | 2024 | 38101397 | PubTator, text mining | PubMed |
| Tetrahydropalmatine from medicinal plants activates human glucokinase to regulate glucose homeostasis. | Biotechnol Appl Biochem | 2024 | 38037220 | PubTator, text mining | PubMed |
| Current Insight on the Role of Glucokinase and Glucokinase Regulatory Protein in Diabetes. | Mini Rev Med Chem | 2024 | 37612862 | PubTator, text mining | PubMed |
| Systematical analysis of underlying markers associated with Marfan syndrome via integrated bioinformatics and machine learning strategies. | J Biomol Struct Dyn | 2024 | 37449753 | PubTator, text mining | PubMed |
| Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemia-induced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications. | Front Endocrinol (Lausanne) | 2023 | 38292764 | PubTator, text mining | PubMed |
| Relationship between GCKR gene rs780094 polymorphism and type 2 diabetes with albuminuria. | World J Diabetes | 2023 | 38222779 | PubTator, text mining | PubMed |
| Gout and Migraines: Exploring the Complex Link in a 16-Year Longitudinal Study of the Korean Population. | J Clin Med | 2023 | 38202145 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2646/papers?page=9